Latest News about Psoriasis
Recent news which mentions Psoriasis
From Benzinga
From Benzinga
Empowering Psoriasis Patients Through Mental Health Support
October 24, 2022
Tickers
BMY
From Misdiagnosis to Building a Support System: Royce Thomas' Experience Living With Psoriasis
April 25, 2022
Tickers
BMY
Roivant' Dermavant Showcases New Long-Term Durability, Tolerability Data For Plaque Psoriasis Candidate
March 25, 2022
Tickers
ROIV
From Benzinga
From Benzinga
Arcutis' Roflumilast Cream For Psoriasis Goes Under FDA Review
December 23, 2021
Tickers
ARQT
From Benzinga
Can-Fite Expects Data Readout From Late-Stage Psoriasis Study With Piclidenoson In Q1 2022
December 07, 2021
From Benzinga
Amgen's Otezla Meets Primary Goal In Late-Stage Genital Psoriasis Study
December 02, 2021
Tickers
AMGN
From Benzinga
Bristol Myers' Deucravacitinib Under FDA Review For Plaque Psoriasis
November 29, 2021
From Benzinga
Dermata Stock Jumps On Positive Psoriasis Candidate Data
October 19, 2021
Tickers
DRMA
From Benzinga
Novartis Posts New Data Reinforcing Efficacy, Convenience Of Cosentyx Autoinjector In Psoriasis
September 29, 2021
Tickers
NVS
From Benzinga
Evelo Biosciences Psoriasis Candidate Shows Benefit In Mid-Stage Study
September 27, 2021
Tickers
EVLO
From Benzinga
vTv Therapeutics Stock Gains As Psoriasis Candidate Shows Favorable Safety Profile
September 24, 2021
Tickers
VTVT
From Benzinga
Why Are Dermata Therapeutics Shares Trading Higher Today?
September 21, 2021
From Benzinga
Soligenix To Test Synthetic Hypericin In Psoriasis Patients
September 16, 2021
Tickers
SNGX
From Benzinga
UCB Gets EU Approval For Bimekizumab In Psoriasis
August 25, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.